PET and SPECT Imaging of ALS: An Educational Review

Area of Science:

• Neurology
• Medical Imaging

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with diagnostic challenges.
• Ruling out other conditions is necessary for an ALS diagnosis.
• Noninvasive neuroimaging aids in understanding ALS pathology and brain biochemistry.

Purpose of the Study:

• To review current advancements in ALS imaging techniques.
• To summarize findings from PET and SPECT imaging in ALS patients.
• To enhance understanding of ALS pathophysiology through neuroimaging.

Main Methods:

• Review of studies utilizing positron emission tomography (PET) and single photon emission computed tomography (SPECT) for ALS imaging.
• Analysis of data from [18F]FDG PET scans for brain metabolism.
• Examination of SPECT findings related to regional cerebral blood flow (rCBF).

Main Results:

• PET imaging with [18F]FDG shows distinct metabolic patterns in the ALS brain.
• Other PET radiotracers indicate neuroinflammation, altered neuronal density, and protein aggregation.
• SPECT imaging reveals reduced regional cerebral blood flow (rCBF) in ALS patients compared to controls.

Conclusions:

• Functional neuroimaging with PET and SPECT provides valuable insights into ALS.
• These techniques help elucidate the complex pathophysiology of ALS.
• Continued research in ALS imaging is crucial for diagnosis and understanding the disease.